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TECHNICAL PAPER
3D RNA-seq: a powerful and flexible tool for rapid and accurate differential 
expression and alternative splicing analysis of RNA-seq data for biologists
Wenbin Guoa,b, Nikoleta A Tzioutzioua, Gordon Stephenb, Iain Milneb, Cristiane PG Calixtoa, Robbie Waugha,c, 
John W. S. Browna,c, and Runxuan Zhangb
aDivision of Plant Sciences, University of Dundee at the James Hutton Institute, Dundee, UK; bInformation and Computational Sciences, The James 
Hutton Institute, Dundee, UK; cCell and Molecular Sciences, The James Hutton Institute, Dundee, UK
ABSTRACT
RNA-sequencing (RNA-seq) analysis of gene expression and alternative splicing should be routine and 
robust but is often a bottleneck for biologists because of different and complex analysis programs and 
reliance on specialized bioinformatics skills. We have developed the ‘3D RNA-seq’ App, an R shiny App 
and web-based pipeline for the comprehensive analysis of RNA-seq data from any organism. It repre-
sents an easy-to-use, flexible and powerful tool for analysis of both gene and transcript-level gene 
expression to identify differential gene/transcript expression, differential alternative splicing and differ-
ential transcript usage (3D) as well as isoform switching from RNA-seq data. 3D RNA-seq integrates state- 
of-the-art differential expression analysis tools and adopts best practice for RNA-seq analysis. The 
program is designed to be run by biologists with minimal bioinformatics experience (or by bioinforma-
ticians) allowing lab scientists to analyse their RNA-seq data. It achieves this by operating through 
a user-friendly graphical interface which automates the data flow through the programs in the pipeline. 
The comprehensive analysis performed by 3D RNA-seq is extremely rapid and accurate, can handle 
complex experimental designs, allows user setting of statistical parameters, visualizes the results 
through graphics and tables, and generates publication quality figures such as heat-maps, expression 
profiles and GO enrichment plots. The utility of 3D RNA-seq is illustrated by analysis of data from a time- 
series of cold-treated Arabidopsis plants and from dexamethasone-treated male and female mouse 
cortex and hypothalamus data identifying dexamethasone-induced sex- and brain region-specific differ-
ential gene expression and alternative splicing.
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Introduction
RNA-seq is generally considered the method of choice to 
analyse gene expression. The availability of programs such 
as Salmon [1] and Kallisto [2] to quantify transcript and gene- 
level expression accurately and rapidly allows transcript-level 
analyses to be both feasible and routine. However, the analysis 
is often a source of frustration for experimental biologists. 
The key issues are: 1) reliance on the skills of often over- 
stretched bioinformaticians with the necessary skills to per-
form the analysis; 2) variation in expertise and knowledge of 
state-of-the-art methodologies among different bioinformati-
cians and the continued use of out-of-date and error prone 
methods/programs (such Tophat [3] and Cufflinks [4]) affect-
ing the quality and reproducibility of analysis; 3) variation in 
suitability and accuracy of different RNA-seq analysis pro-
grams; 4) variation in level of bioinformatics support and 
access to bioinformaticians’ time (e.g. early career scientists 
often have more limited access to sufficient bioinformaticians’ 
time); 5) cost of organizational bioinformatics support; 6) 
length of time commonly needed (often many months) to 
generate the data analysis; 7) limitations of many RNA-seq 
differential expression analysis programs to handle complex 
experimental designs (e.g. time-course or developmental ser-
ies data); and 8) despite the ever-increasing appreciation that 
alternative splicing (AS) is an important level of post- 
transcriptional regulation, most RNA-seq analyses still focus 
on the gene-level expression thereby ignoring important 
information that is in the data.
3D RNA-seq is an interactive tool for RNA-seq analysis that 
is implemented using the R Shiny App. It can be run locally or 
accessed through a web interface (https://3drnaseq.hutton.ac. 
uk/). It has been developed to carry out 1) differential expres-
sion (DE) analysis of genes and transcripts; 2) differential alter-
native splicing (DAS) and 3) differential transcript usages 
(DTU) for RNA-seq data, hence 3D RNA-seq. Isoform switch 
(IS) analysis for pairwise [5] and time-series [6] are also incor-
porated into 3D RNA-seq for advanced AS analysis. The defini-
tions of DE, DAS, DTU and IS are explained in Fig. 1A-C. The 
program integrates the state-of-the-art, highly rated differential 
expression analysis tool, Limma [7,8], and adopts current best 
practice for RNA-seq analysis (Fig. 2). 3D RNA-seq can be used 
regardless of the type of sample or species under investigation, it 
can handle complex experimental designs and standardizes the 
analysis process. An easy-to-use graphical interface takes users 
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through the different steps of the analysis, visualizes the inter-
mediate and final results through graphics and tables, and 
generates publication quality figures such as heat-maps, volcano 
plots, histograms, Venn diagrams and expression profiles. 
Finally, a comprehensive report is automatically generated at 
the end, which captures all the input info, each parameter used 
in every step of the analysis, all of the intermediate figures and 
tables generated as well as the methodologies used at each step. 
The full analysis report shows the key findings from the analysis 
and it provides a useful tool to diagnose the technical issues with 
the RNA-seq experiment and analysis. More importantly, it 
provides the ultimate guarantee of reproducible analyses.
There are six main advantages of 3D RNA-seq: 1) accessi-
bility, ease-of-use, extensive visualization and flexibility allows 
experimental biologists to control the analysis of their own 
data; 2) acceleration of RNA-seq analyses – in a typical ana-
lysis, RNA-seq data quality control, pre-processing and tran-
script quantification, the full differential expression/AS 
analysis and report generation using 3D RNA-seq can be 
completed in less than three days; 3) ability to handle complex 
experimental designs; 4) transcript-level analysis for accurate 
differential expression and differential AS; 5) generation of 
customized report with details of parameters and figures and 
tables; and 6) providing consistency and reproducibility in 
RNA-seq analysis to promote open science. We have demon-
strated the applicability of 3D RNA-seq to different species by 
analysing RNA-seq data from complex experiments in 
Arabidopsis and mouse. The Arabidopsis analysis illustrates 
its application to time-series RNA-seq data while the mouse 
data show its ability to analyse data from experiments with 
multi-factorial designs. In the latter, comparison to the origi-
nal differential gene expression analysis [9] and an advanced 
analysis of the same data with Sleuth [10,11], 3D RNA-seq 
provided far greater resolution in identifying dexamethasone- 
induced changes in both differential expression and differen-
tial alternative splicing.
Results
Application of 3D RNA-seq to RNA-seq analyses of 
expression/AS in plants
To demonstrate its utility, 3D RNA-seq was applied to a subset 
of data from an RNA-seq time-series of Arabidopsis plants 
Figure 1. Definitions and criteria for identification of genes and transcripts with significant DE, DAS and DTU. The lines in the expression profile plots depict 
the average gene and transcript expression changes between two conditions C1 and C2. Total gene expression (blue) is the sum of the expression of all individual 
transcripts (red, green or yellow). The percentage values represent the expression ratios of transcripts to the gene. A) DE genes and transcripts are those whose 
abundance changes between conditions, as measured by changes in log2 fold change (L2FC). B) DAS genes must have more than one transcript and are determined 
by comparing the expression changes between individual transcripts to the gene level between conditions. The change in percentage spliced (ΔPS) is calculated as 
the percentage change in the abundance of a transcript compared to the total expression from gene. For a gene to be DAS, besides a pre-set p-value cut-off, at least 
one transcript must have a ΔPS ≥0.1. C) DTU transcripts are those transcripts which show different expression behaviour from the other transcripts of the same gene. 
They are determined by comparing the change in expression of each transcript to the average expression change of all the remaining transcripts of the gene. With 
these criteria, A) DE only genes are those where the gene and transcript expression levels change significantly but transcripts do not change their relative abundance 
within a gene. B) DAS only genes are those where the gene expression level does not change significantly but that of at least one transcript changes its relative 
abundance within a gene. C) DE+DAS genes show both significant gene-level expression changes and relative abundance changes of at least one transcript. Isoform 
switches [ISs) happen when a pair of transcripts reverse their relative abundance across different conditions or time points.
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Figure 2. 3D RNA-seq analysis pipeline.
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exposed to cold stress (Supplementary Figure S1) [12,13]. 
Briefly, Arabidopsis Col-0 plants were grown at 20°C for 5 
weeks, then the temperature was reduced to 4°C. Samples 
were harvested every 3 hours for the last day at 20°C, Day 1 
at 4°C and Day 4 at 4°C, yielding 26 time-points in total 
(Supplementary Figure S1A). The data from six of these time- 
points was extracted to illustrate the utility of 3D RNA-seq. 
The six time-points are 3 and 6 h into the dark period from 
the 20°C Day, Day 1 and Day 4 at 4°C (time points T2 and T3, 
T10 and T11, and T19 and T20, respectively, referred to here 
as time-points T2 and T3 from Day 0, Day 1 and Day 4 
(Supplementary Figure S1A). The T2 and T3 time-points 
represent the equivalent time-point in the three days and 
thereby control for time-of-day expression variation. 
Transcript quantification was generated using Salmon [1] 
and AtRTD2-QUASI [14].
In the data pre-processing procedure, we removed the low 
expressed genes/transcripts using the mean-variance trend plots 
(Supplementary Figure S2) [7] and corrected batch effects using 
the RUVSeq method [15] in the App (Supplementary Figure S3). 
Expression data were normalized across samples to reduce 
sequencing biases. We also employed stringent filters to control 
the FDR of multiple testing.
Using 3D RNA-seq, contrast groups were set up to compare 
the equivalent time-points before and after cold stress to control 
for time-of-day variation in expression due to photoperiodic and 
circadian changes [12]. For example, T10 (T2 in day 1 at 4°C) 
was compared to T2 in day 0 (20°C), T19 (T2 in day 4 at 4°C) 
was compared to T2 in day 0 (20°C) and so on (Supplementary 
Figure S1B). Other contrast groups can also be set up 
(Supplementary Figure S4). For example, the mean between 
T10 and T11 (T2 and T3 in day 1 at 4°C) can be compared to 
the mean of T2 and T3 in day 0 (20°C) etc. or the difference 
between T10 and T11 (T2 and T3 in day 1 at 4°C) can be 
compared to the difference between T2 and T3 in day 0 (20°C) 
etc. (Supplementary Figure S1C). We identified 5,023 DE genes 
and 2,346 DAS genes. These included 1,875 genes which were 
regulated only by AS (no significant differential expression at the 
gene level) and 4,185 DTU transcripts (Fig. 3A,B). In addition, 
471 of the DAS genes also had significant abundance (DE) 
changes across the contrast groups (DE+DAS genes). The abun-
dance of significant DTU transcripts can either change signifi-
cantly (DE+DTU) or non-significantly (DTU-only) (Fig. 1C). 
Output histograms illustrate the variation in up- and down- 
regulation of DE genes and the number of significant isoform 
switches between the contrast groups (Fig. 3C,D). Volcano plots 
of fold changes in abundance (log2FC) against significance 
(FDR) highlight those DE genes and transcripts with the largest 
and most significant changes in the data (Fig. 3E). Heat maps of 
clustered DE genes and DTU transcripts are shown for the 
contrast groups of the six time-points in Fig. 4A and 
B. Functional annotation analysis was performed using 
RDAVIDWebService R package with significance threshold 
FDR < 0.05 [16]. The DE genes showed GO enrichment in cold- 
induced physiological and molecular events such as response to 
various stresses, transcription and altered ribosome production 
(Fig. 4C). Similarly, DAS genes were significantly associated with 
the spliceosome, RNA splicing and nucleotide/RNA/mRNA 
binding terms reflecting cold-induced AS of splicing factors 
(Fig. 4D). The Kyoto Encyclopaedia of Genes and Genomes 
(KEGG) pathway enrichment analysis showed DE genes were 
significantly enriched with Starch and sucrose metabolism, 
Biosynthesis of secondary metabolites, Plant hormone signal 
transduction, Ribosome biogenesis in eukaryotes, 
Photosynthesis – antenna proteins, Plant–pathogen interactions 
and Glutathione metabolism pathways, while the DAS genes 
were related to Spliceosome and mRNA surveillance pathways 
(Supplementary Table S1). These results reflect the analysis of 
the complete time-series [12]. Experimental validation of expres-
sion, AS and isoform switches by high-resolution RT-qPCR and 
high-resolution RT-PCR have been described previously [12,13].
The TSIS analysis identified 1,688 significant switches 
between 1,144 pairs of alternatively spliced transcript isoforms 
in DAS genes with stringent cut-offs: probability >0.5, sum of 
average abundance differences >1 TPM and p-value <0.05 
(Fig. 3D) [6]. These ISs were related to various AS events 
and approximately half of the isoforms were protein-coding 
transcripts with different functions according to the transcript 
annotations in AtRTD2 [14]. The switch frequency along the 
time-series showed that ISs occurred in the contrast groups 
comparing 4°C and 20°C time-points (Fig. 3D). Thus, a large 
number of genes and transcripts in Arabidopsis are sensitive 
to temperature reduction and likely contribute to acclimation 
and survival through AS regulation.
Application to RNA-seq analyses in animals
To illustrate the utility of the 3D RNA-seq App in analysing 
multi-factor RNA-seq data from animals, we re-analysed 
RNA-seq data which studied the effects of dexamethasone 
treatment on cortical and hypothalamic neural progenitor/ 
stem cells (NPSCs) from male and female mice [9]. The RNA- 
seq data consisted of male and female cortex and hypothala-
mus cell cultures treated or untreated with dexamethasone, 
each with three biological replicates (24 samples in total). The 
study identified differentially expressed genes common and 
unique to brain region, gender and dexamethasone treatment 
[9]. The same dataset has also been used to demonstrate the 
improved resolution of differentially expressed genes using 
Sleuth for transcript-level differential analysis and aggregation 
of transcript level p-values to give gene-level p-values [11]. 
Using these data, we performed two differential expression 
comparisons between: 1) the Sleuth/aggregated p-values 
method [10,11] and 3D RNA-seq and 2) the results of the 
differential analysis in [9] and those generated by 3D RNA-seq 
expression results.
To compare the results from 3D RNA-seq and Sleuth directly, 
the Kallisto transcript quantifications were downloaded (see 
Availability of data and materials) and pre-processed in 3D RNA- 
seq. This identified 43,836 expressed transcripts which had at least 
3 samples with � 1 CPM and 12,155 expressed genes which had 
at least one expressed transcript which were then used in the 
Sleuth and 3D RNA-seq analyses. In addition, the Sleuth analysis 
in Yi et al. [11], only examined the effects of dexamethasone and 
did not distinguish brain region or gender effects and therefore 
the same contrast groups were set up in 3D RNA-seq to match the 
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analysis in Yi et al. [11]. We then ran the Sleuth/aggregated 
p-values pipeline (see Availability of data and materials) and 3D 
RNA-seq on the 43,836 expressed transcripts. Using Sleuth, we 
identified 3,237 DE genes (Fig. 5). GO enrichment analysis was 
performed using Fisher’s exact test in topGO R package [17] in 
conjunction with genome annotation for mouse org.Mm.eg.db 
[18]. KEGG enrichment was queried against the KEGG database 
[19] by using Fisher’s exact test. Significantly enriched GO terms 
in categories of biological process (BP), cellular component (CC) 
and molecular function (MF) and KEGG pathways were deter-
mined with FDR < 0.05. Significant enrichment terms and path-
ways relevant to response to stress, immune system, 
inflammation, hormone response, splicing/spliceosome were 
extracted to illustrate effects of dexamethasone treatment on 
gene function (Fig. 6; Supplementary Table S2). The 3D RNA- 
seq analysis used the same contrast groups and a BH adjusted 
Figure 3. Illustrations of visualization outputs from 3D RNA-seq. A) Summary figure of expressed genes and significant DE, DE+DAS and DAS genes from analysis 
of the Arabidopsis data; B) Summary figure of expressed transcripts and DE, DE+DTU and DTU transcripts; C) Number of significantly up- and down-regulated DE 
genes in different contrast groups, and D) Number of significant isoform switches in contrast groups. E) Volcano plot of significant DE genes. The top 10 genes with 
the smallest p values and biggest fold changes are highlighted and different colours refer to different contrast groups.
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p-value cut-off of <0.05 to identify significant changes [20]. Note 
that to maintain similar parameters for the direct comparison to 
Sleuth, the log2 fold change and Δ percent spliced cut-offs were 
not applied in the 3D RNA-seq analysis. The results of the 3D 
RNA-seq pipeline showed a high degree of similarity with the 
Sleuth pipeline in terms of identified DE genes but in addition 
resolved differentially alternatively spliced genes from DE genes 
and identified 1,649 genes with significant expression/AS changes. 
3D RNA-seq identified a total of 4,284 genes with differential 
expression and/or differential alternative splicing of which 3,700 
and 896 were DE and DAS genes, respectively (with an overlap of 
312 gene – DE+DAS genes) (Fig. 5). The Sleuth pipeline [11], 
Figure 4. Visualization of clustered genes and transcripts and enriched GO terms. Heatmaps show the grouped expression profiles for A) DE genes and B) DTU 
transcripts across the samples. The top-enriched GO terms for C) DE and D) DAS genes are visualized with their associated FDRs.
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which does not identify DAS genes, recovered 3,237 DE genes. Of 
the total (DE and DAS genes) and DE genes identified by 3D 
RNA-seq, 2,635 and 2,346, respectively, were common to both 
analyses such that 81.4% and 72.5% of the total and DE genes 
identified by Sleuth were identified by 3D RNA-seq (Fig. 5). The 
3D RNA-seq pipeline also identified 5,573 DE transcripts and 
1,480 DTU transcripts with adjusted p-value <0.05. Interestingly, 
531 of the DAS genes were among the DE genes defined by 
Sleuth – of these, 242 were DE+DAS. Of the 602 DE genes unique 
to the Sleuth analysis, 372 had significant DE/DTU transcripts in 
3D RNA-seq and did not carry over to significant DE or DAS 
genes (Fig. 5).
The resolution of DE and DAS genes by 3D RNA-seq was also 
illustrated in the GO and KEGG pathway enrichment annota-
tions. The DE genes from Sleuth had significant terms and 
pathways that related to response to stress, response to hormone 
and immune system as well as multiple splicing/spliceosome 
terms indicating alternative splicing regulation of gene expres-
sion (Fig. 6A; Supplementary Table S2A). The separation of DE 
and DAS genes by 3D RNA-seq resolved the majority of stress, 
hormone and immune response terms to DE genes (transcrip-
tional regulation) (Fig. 6B; Supplementary Table S2B) and the 
splicing enrichment terms (such as spliceosome and mRNA 
surveillance pathways) to the DAS genes (AS regulation) (Fig. 
6C; Supplementary Table S2C). In addition, the 1,284 DE genes 
unique to the 3D RNA-seq analysis (Fig. 5) were enriched for 
steroid hormone receptor activity (Fig. 6D) reflecting the nature 
of the chemical treatment.
The second comparison exploited the flexibility of 3D RNA- 
seq to analyse the effects of multiple factors and detect sex- 
specific and brain region-specific DE and DAS genes and tran-
scripts in the mouse data. In the original study, the effects of 
dexamethasone treatment on gene expression in NPSCs from 
different brain regions (cortical and hypothalamic) and sexes 
(male and female), were examined [9]. We therefore set up 
contrast groups (i.e. Female.Cortex.Dex vs Female.Cortex. 
Vehicle (untreated control), Male.Cortex.Dex vs Male.Cortex. 
Vehicle, Female.Hypothalmus.Dex vs Female.Hypothalmus. 
Vehicle and Male.Hypothalmus.Dex vs Male.Hypothalmus. 
Vehicle). The cut-offs were set as adjusted p-value <0.05, L2FC �
1 and ΔPS � 0:1: Across the four contrast groups, the 3D pipe-
line identified 930 DE genes and 509 DAS genes, of which 462 
were only regulated by AS, and 2,121 DE transcripts and 628 
DTU transcripts, of which 455 were AS regulated only. The 
results of individual contrast groups revealed that 1) both tran-
scription and AS regulation were much more affected in cortex 
cells than in hypothalamic cells (Fig. 7A-C) and 2) more genes 
and transcripts were down-regulated in cortex cells while in 
hypothalamic cells up-regulation dominated the expression 
changes (Fig. 7A-C). The relative differences between brain 
regions at the DE gene level was described by Frahm et al. [9]. 
We also compared the DE genes from the 3D pipeline to those of 
[9] which used a p-value cut-off of <0.05 [note: p-values were not 
adjusted and no L2FC cut-off was applied). There were 449 DE 
genes in common and 908 significant DE genes in [9] were 
filtered out in the 3D pipeline due to low L2FC or insignificant- 
adjusted p-values (Fig. 7D]. Although stringent filters were used, 
the 3D analysis identified 481 unique DE genes. Finally, the 
isoform switch analysis identified 63 significant ISs of DAS 
genes in the contrast groups (Fig. 7E). Thus, compared to the 
Sleuth pipeline, 3D RNA-seq provides both transcript- and gene- 
level analysis to resolve both genes and transcripts differentially 
expressed due to transcriptional regulation, gene and transcript 
expression changes due to AS regulation by identifying novel 
DAS genes, DTU transcripts and ISs. The re-analysis of the 
mouse data with 3D RNA-seq demonstrates how novel informa-
tion can be unlocked from publicly available RNA-seq data 
which has only been used to analyse differential gene-level 
expression. Finally, dexamethasone has recently gained promi-
nence reducing mortality in hospitalized patients with COVID- 
19 that require mechanical ventilation, supplementary oxygen, 
or Extra Corporeal Membrane Oxygenation (ECMO) (https:// 
www.sps.nhs.uk/articles/dexamethasone-and-covid-19/). Our 
results raise the questions of whether dexamethasone treatment 
might affect expression or alternative splicing of endogenous 
genes in patients. 3D RNA-seq would be a valuable tool inves-
tigating such questions.
Discussion
3D RNA-seq is easy to use and designed for the maximum 
take-up by biologists
3D RNA-seq has the potential to revolutionize transcriptomics 
analysis by opening up RNA-seq analysis to wet lab scientists/ 
biologists with little or no bioinformatics experience. The 3D 
RNA-seq web-based application requires no installation and 
no programming skills from users. The whole analysis can be 
accomplished entirely within a web browser. The pipeline 
consists of 24 single steps within seven tabbed panels. It 
integrates widgets that provide users with technical summa-
ries of the research behind each step so that they can set the 
parameters appropriate for their studies. Recommended para-
meters are also given in the manual and are used as defaults. 
Tutorial and demonstration videos are available on YouTube 
(see Availability of data and materials). More importantly, 3D 
RNA-seq integrates interactive visualization at every step of 
the analysis so that users can visualize the changes caused by 
modification of the parameters as they move through the 
Figure 5. Comparison of the gene lists generated by 3D RNA-seq and 
Sleuth pipelines. The RNA-seq data on dexamethasone treatment of mice 
cells was taken from 9. Comparable parameters were applied when running 
3D RNA-seq and Sleuth. The Venn diagram compares the DE genes from Sleuth 
to DE and DAS genes and DE and DTU transcripts from 3D RNA-seq.
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pipeline. Interactive visualization not only helps the user to 
understand the method behind each step better, but it also 
enables users to explore the optimum settings for the analysis, 
and ultimately offers reassurance and robustness in the 
results.
3D RNA-seq also allows the analysis of RNA-seq data with 
simple and complex experimental designs, such as time-series and 
developmental series data etc. The comparisons (contrast groups) 
can be set up between any pairs or groups of samples to cater for 
different investigations, a feature that is important for the 
Figure 6. Top-enriched GO terms identified from 3D RNA-seq and Sleuth. The Fisher’s exact test and topGO R package were used to generate significant 
enrichment gene ontology (GO] terms with FDR < 0.05. Significant terms relevant to response to stress, immune system, inflammation, hormone response, splicing/ 
spliceosome are shown in the figure. A) Significantly enriched GO terms of DE genes from Sleuth; B) Significantly enriched GO terms of DE genes from 3D RNA-seq; C) 
Significantly enriched GO terms of DAS genes from 3D RNA-seq; and D) Significantly enriched GO terms of novel DE genes unique to 3D RNA-seq. Splicing/ 
spliceosome-related GO terms are enriched in the DE genes in Sleuth (red dashed box in A) but are found in GO terms associated with DAS genes in 3D RNA-seq (C). 
BP: Biological process; BP_splice: Biological process with terms of splice, splicing, spliceosome and spliceosomal; CC: Cellular Component; MF: Molecular Function.
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universal applicability of 3D RNA-seq for RNA-seq analysis. The 
3D RNA-seq App can be used to analyse RNA-seq data from any 
species for which transcript quantifications using Salmon/Kallisto 
can be generated. We use Salmon or Kallisto because they are 
fastest and most accurate quantification methods for RNA-seq 
analysis. The accuracy of the quantifications using Salmon and 
Kallisto will depend on the quality and comprehensiveness of the 
reference transcriptome used to generate the transcript quantifi-
cations [14,21,22]. Multiple factors such as missing transcripts, 
transcript redundancy, transcript fragments and mis-annotations 
at the 5ʹ and 3ʹ ends of isoforms can drastically affect accuracy of 
transcript quantification [14,22–24]. For many species, compre-
hensive, optimized transcriptomes do not exist and using partial, 
incomplete transcriptomes and/or which have not been filtered to 
remove such erroneous isoform information will also produce an 
inaccurate transcript and AS quantification. As transcriptomes 
improve for many species, transcript quantification and results 
from 3D RNA-seq will also improve.
The speed and accuracy of the 3D RNA-seq analysis have the 
potential to revolutionize gene expression research programmes. 
Generation of transcript quantifications and running 3D RNA- 
seq is performed in less than three days. It reduces an analytical 
step which previously required skilled bioinformaticians and 
often took many weeks or even months to complete. This is 
significant not only in terms of satisfaction in result generation 
for the individual scientists/biologists but also for strategic 
Figure 7. Sex-specific and tissue-specific expression analysis using 3D RNA-seq on the mouse data. Contrast groups were designed to investigate Dex-induced 
expression and alternative splicing changes between male and female and cortex and hypothalamus brain regions. Significant DE gene/transcript lists were 
generated by BH adjusted p-value < 0.05, L2FC � 1 and ΔPS � 0.1. A) Up- and down-regulated DE genes and B) DE transcripts. C) Summary of statistical analysis 
results from 3D RNA-seq in each contrast group. D) Venn diagram comparing the DE genes in the 3D RNA-seq analysis to the results in Frahm et al. [9], in which the 
significant DE genes were determined by p-value < 0.05 (multiple testing adjustment and L2FC cut-off were not applied). 92 genes had low expression and were not 
included in the transcriptome quantification in 3D RNA-seq analysis. E) the number of Isoform switches in different contrast groups with the following cut-offs: 
probability of switch � 0.5, difference of average TPMs at different conditions � 1 TPM and adjusted p-value of the TPM difference < 0.05.
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planning of research programmes where now multiple, conse-
cutive RNA-seq experiments can be planned within the period of 
a funding proposal. More importantly, the rapid turn-over of the 
analysis provided by 3D RNA-seq creates a level playing field for 
research groups with very different access to bioinformatics 
expertise or resources thereby supporting, in particular, smaller 
groups and early-career scientists. 3D RNA-seq will also aid 
research projects in developing countries with limited access to 
computational infrastructures and bioinformatics expertise. 
Although the quantification of transcripts is not included in 
3D RNA-seq, we have provided a tutorial document and 
YouTube video on performing such tasks using publicly avail-
able Galaxy servers (https://usegalaxy.eu/) (see Availability of 
data and materials). The transcript quantification output from 
Galaxy can be used as input to 3D RNA-seq directly.
3D RNA-seq facilitates speedy publication of RNA-seq 
analysis and improves the transparency and 
reproducibility of the analysis
The fast turn-over of the analysis provided by 3D RNA-Seq 
will present a significant advantage for speedy publication of 
the results. In 3D RNA-seq, multiple types of figures/summa-
ries are generated and saved including commonly used visua-
lizations such as heatmaps, GO enrichment plots, expression 
profile plots, volcano plots etc. Users can easily generate and 
save new figures for each new set of parameters. The format, 
resolution and size of the figure can be customized and pre-
viewed in 3D RNA-seq before saving. In addition, the signifi-
cant DE/DAS/DTU/IS gene and transcript lists are saved for 
further interpretation. The final technical report generated in 
the final step of 3D RNA-seq records each step in the analysis 
with the parameters used and integrates all the saved figures. 
The report is comprehensive, accurate and reproducible 
including all the information required for ‘Material and 
Methods’ sections for the RNA-seq analysis as well as figures 
for the Results and Supplementary Materials. Furthermore, 
some publications have very poor technical descriptions of the 
methods and parameters used for RNA-seq analyses. In 
future, submission of such a report along with manuscripts 
to scientific journals would facilitate transparency and allow 
reviewers to identify issues with the analysis and how it relates 
to other published work.
3D RNA-seq provides enhanced alternative splicing 
analysis at the transcript level
Over the last 20 years, genome-wide expression analyses have 
relied on microarrays and more recently, RNA-seq analyses 
mostly at the gene level. RNA-seq allows gene expression to 
be analysed at the level of both genes and transcripts which in 
turn provides a means to study post-transcriptional processes 
such as alternative splicing. AS regulation plays key roles in gene 
expression and novel genes with altered gene expression at the 
AS level have been found in most of the RNA-seq studies. 
Despite the importance of AS and the potential to include AS 
analysis routinely in RNA-seq, AS is still largely ignored. For 
example, 4,065 publications from the Web of Science Core 
Collection (2008–2019) (https://wok.mimas.ac.uk/) were 
retrieved with the term ‘RNA-seq differential gene expression’, 
but only ca. 289 included ‘differential alternative splicing’. 3D 
RNA-seq provides by far the most detailed differential expres-
sion analysis on the transcript and alternative splicing level. In 
particular, it allows the identification of both DAS genes and 
DTU transcripts which are differentiated from DE genes/tran-
scripts and a range of measurements, visualizations and statis-
tical tests provide a comprehensive analysis of alternative 
splicing alongside differential expression. Additionally, 3D 
RNA-seq has also integrated methods that detect isoform 
switches which can play pivotal roles in re-programming of 
gene expression through switching of functionally different 
transcript isoforms between, for example, normal and tumour 
tissues to provide signatures for cancer diagnostics and prog-
nostics [5]. With the enhanced AS analysis in 3D RNA-seq, key 
and novel genes under AS regulation which underpin important 
biological processes can be identified and provide new targets 
for medical intervention or crop improvement.
3D RNA-seq unlocks the discovery potential for RNA-seq 
data
Finally, the speed of 3D RNA-seq now makes it feasible for 
biologists to re-analyse existing or publicly available RNA-seq 
data to give improved differential expression analysis and novel 
AS information as demonstrated here for the mouse data. 
Datasets from different labs can now be quickly compared 
using the same parameters and without performing new experi-
ments. In addition, with new transcriptome releases, it is feasible 
to re-analyse datasets and update results. 3D RNA-seq provides 
a reproducible platform to standardize analyses and utilize new 
and existing data for improved resolution and interpretation. 3D 
RNA-seq can be used to analyse expression and AS of non-coding 
RNAs as long as they are annotated in the reference transcrip-
tome [13]. In the future, we aim to adapt the pipeline for third- 
generation direct RNA sequencing as well as small RNA analysis.
Materials and methods
We have developed 3D RNA-seq App, an R package which 
provides a web-based shiny App for flexible and powerful 
differential expression and alternative splicing analysis of 
RNA-seq data. The program is designed for ease-of-use 
and can be run by biologists with minimal bioinformatics 
experience or by bioinformaticians with little exposure to 
RNA-seq analysis.
The whole analysis from transcript quantification to data 
pre-processing, differential gene and transcript expression, 
differential alternative splicing, differential transcript usage 
and isoform switching analysis can be performed in less 
than three days. The analysis is optimized with quality 
control plots and generates a report containing customiz-
able publication-quality figures and data tables to aid inter-
pretation of results.
3D RNA-seq enables routine analysis of differential alter-
native splicing and isoform switching and can handle complex 
experimental designs. The speed and accuracy of the analysis 
have the potential to revolutionize what is achievable with 
RNA-seq technology.
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Input files for 3D RNA-seq App
Three simple input files are required for 3D RNA-seq analysis 
(Supplementary Figure S5). 1) A meta-data table in ‘csv’ 
(comma delimited) format containing the information of 
experimental design, including conditions/treatments, biolo-
gical replicates, sequencing replicates (same biological sample 
divided and sequenced on different sequencing lanes) and 
quantification file names (Supplementary Figure S5A). 2) 
Transcript quantification outputs generated using Salmon 
[1] or Kallisto [2] (Supplementary Figure S5B). Transcript 
quantification is the first difficulty for most biologists who 
lack programming skills. A detailed user manual with demo 
video of quantification by using Salmon/Kallisto on the 
Galaxy interface [25] has been provided (see Availability of 
data and materials). 3) A transcript-gene association file con-
sisting of a ‘csv’ spreadsheet with the first column listing 
transcript names and second column listing gene IDs. This 
relates transcript names to gene IDs which allows expression 
analysis at both gene and transcript level and the AS analysis 
within each gene (Supplementary Figure S5C). It is also pos-
sible to extract this info from other files when that informa-
tion is available (Supplementary Figure S5D and E). All the 
inputs can be easily uploaded by selecting corresponding files 
from a local computer.
Data pre-processing with optimal quality control
First, Salmon and Kallisto outputs (‘quant.sf’ from Salmon 
and ‘abundance.tsv’ from Kallisto) for each sample, will be 
imported into 3D RNA-seq and read counts will be gener-
ated using the tximport R package [26], which takes into 
account the transcript length and library size. Sequencing 
replicates, if present, will be merged to increase sequencing 
depth. Then, the data is pre-processed in various steps to 
reduce noise (e.g. removal of low expressed genes and 
transcripts) and technical variance (e.g. batch effects). In 
each step, interactive visualization plots are produced to 
show the immediate impact of the parameter change and 
facilitate the optimization of parameters for pre- 
processing. 1) Removal of low expressed transcripts. RNA- 
seq read counts follow approximately the negative binomial 
distribution. The variance of log2 transformed read counts 
decreases monotonically with the increase of mean 
(Supplementary Figure S2) [7,27,28]. However, low 
expressed transcripts do not follow such a distribution 
and thus should be removed. On the basis that an 
expressed transcript should have a minimum count 
per million (CPM), n, in at least m samples, the cut-off 
can be adjusted by the user and the effect on mean-variance 
trends visualized immediately. 2) Similarities and differ-
ences between samples are visualized by Principal 
Component Analysis (PCA) plots (Supplementary Figure 
S3). PCA is a method to project data variance of thousands 
of variables (transcripts/genes) to a few principal compo-
nents (PC) that capture the majority of the data variability. 
PCA plots can reveal major variances in an experiment in 
an unbiased manner which allows technical effects (e.g. 
batch effects among biological replicates caused by different 
experimental conditions) to be identified. 4) Correction of 
technical effects if required. Batch effects, if detected, can 
be corrected by different methods such as the RUVSeq 
R package, which estimates a co-efficient for batch effect 
term which can be incorporated into the design matrix with 
the main factors in linear regression models for 3D analysis 
(Supplementary Figure S3B) [15]. 5) Normalization of read 
counts across the libraries. Read counts can be normalized 
using Trimmed Mean of M-values (TMM), Relative Log 
Expression (RLE) or upper-quartile method [29]. Read 
count distributions before and after normalization can be 
visualized in the plots.
Principle of 3D analysis: identification of DE, DAS and 
DTU genes and transcripts
RNA-seq experimental designs often involve a single, or 
multiple experimental conditions that may affect gene 
expression. The 3D RNA-seq App provides a flexible way 
to set up contrast groups where users can select any sam-
ples or groups of samples of interest for comparison. Thus, 
it allows analyses of both simple pair-wise comparisons and 
complex experimental designs such as time-series, develop-
mental series and multiple conditions (Supplementary 
Figure S4). For each contrast group, different statistics are 
defined for robust DE/DAS/DTU (3D) predictions (Fig. 1A- 
C). 1) For differential expression, log2 fold change (L2FC) is 
the difference of log2-CPM values in contrast groups; 2) for 
differential alternative splicing, Δ percent spliced (ΔPS) is 
the difference of PS values which are defined as the ratios 
of transcript average abundances divided by the average 
gene abundances; and 3) p-values of multiple comparisons 
are adjusted to control the false discovery rate (FDR) 
[30, 31].
Stringency of the analysis can be modified by changing 
the cut-off settings. A gene/transcript is identified as DE in 
a contrast group if L2FC of expression is greater than or 
equal to an established cut-off value (e.g. L2FC ≥ 1) and 
with adjusted p-value less than a cut-off (e.g. p< 0.01 or 
0.05) (Fig. 1A). At the AS level, gene expression is com-
pared to transcript expression in the contrast groups [8]. 
To identify DAS genes, the expression of each transcript is 
compared to the weighted average expression of all the 
transcripts for the same gene (weight on transcript expres-
sion variance). The p-value of each test is converted to 
gene-wise p-value by using the F-test or Simes method [8] 
(Fig. 1B). To identify DTU transcripts, each transcript is 
compared to the weighted average of all the other tran-
scripts of the same gene (Fig. 1C). A gene is DAS in 
a contrast group if the adjusted p-value is less than an 
established cut-off value and at least one transcript of the 
gene has a ΔPS greater than an established cut-off value 
(e.g. ΔPS >0.1) (Fig. 1B). A transcript is DTU if the 
adjusted p-value and absolute values of ΔPS is greater 
than the selected cut-off values, respectively (Fig. 1C). 3D 
RNA-seq thereby identifies significant DE genes and tran-
scripts, DAS genes and DTU transcripts and these results 
RNA BIOLOGY 11
are saved in summary figures (see Fig. 3A,B), and tables of 
identified transcript/gene lists in csv files.
3D RNA-seq is flexible and can work with all experimental 
designs
Within 3D RNA-seq, the contrast groups (comparisons) can be 
set-up in multiple ways: 1) between any two samples with 
biological replicates not just limited to the comparison to control 
samples only; 2) between groups of samples, where the samples 
can be grouped at a higher level (e.g. group samples by gen-
der); 3) contrast groups can be set up to test the interactions of 
different factors (e.g. the interactions between gender and treat-
ment. Do different genders respond to the treatment differ-
ently?); 4) Besides discrete comparisons of samples and groups, 
3D RNA-seq also allows the comparison of trend changes over 
time in each parallel condition group by using the spline method 
[31] to study dynamic activities and changes of transcriptome 
over time and over several conditions simultaneously. For exam-
ple, the identification of the dynamics of stress-responsive genes 
and AS events in plants [12,13,32,33], timing mechanisms of 
circadian clocks [34, 35, 36] and drug responses [37,38]. 
Adjusted p-values are used to report the genes and transcripts 
that show significant differences between samples/groups/series 
at both levels of transcription and AS (DE, DAS and DTU).
Transcript isoform switch analysis
Transcript isoform switches (ISs) are a prominent type of DAS 
within a gene where a pair of alternatively spliced isoforms 
reverse the order of their relative expression abundances in 
response to stimulus [6]. In the 3D RNA-seq analysis pipeline, 
the iso-kTSP method is introduced to study the ISs between 
pair-wise conditions in the user-defined contrast groups [5] 
while the Time-Series Isoform Switch (TSIS) method is used 
to identify the ISs between any consecutive time-points in time- 
series or developmental data [6].
Outputs and visualization
3D RNA-seq allows users to save results of significant DE/DAS/ 
DTU gene/transcript lists, intermediate data of the whole analy-
sis and publication-quality plots to a local folder by clicking 
‘action’ buttons at the various steps in the App. Four folders 
are created to save 3D analysis outputs, ‘result’, ‘figure’, ‘report’ 
and ‘data’. The gene and transcript expression in read counts and 
TPMs, testing statistics and analysis results of 3D analysis will be 
saved as ‘.csv’ files in the ‘result’ folder. All the figures of data pre- 
processing, 3D analysis and downstream visualization are saved 
as ‘png’ and ‘pdf’ formats with user specified width, height and 
resolution in the ‘figure’ folder. The intermediate variables gen-
erated during 3D analysis are saved as ‘.RData’ R objects in the 
‘data’ folder for R users to carry out further analysis if required. 
In the last step of 3D analysis, a report in three formats, ‘html’, 
‘pdf’ and ‘word’, will be generated in the ‘report’ folder using 
R Markdown [39]. The report includes sections of ‘Methods’, 
‘Results’, ‘Supplementary figures’, ‘Supplementary material’ and 
‘References’, in which all the parameters selected by the users for 
each step are recorded. The publication-quality figures and 
reports provide all information required for publications and it 
also provides sufficient information to reproduce the same ana-
lysis and results.
Genes and transcripts that are significantly changed 
between contrast groups can be visualized within the App in 
Venn diagrams, histograms and volcano plots (e.g. the num-
ber of up- and down-regulated DE genes and transcripts, 
isoform switches etc.) (see Fig. 3C-E). Heat-maps are used 
to visualize co-expression clusters of significant 3D genes and 
transcripts and investigate their expression pattern changes 
across conditions (Fig. 4A,B). Individual gene and transcript 
profiles and ΔPS plots can be generated to give users intuitive 
visualization of those with significant abundance and AS 
changes, thereby allowing a convenient and detailed investi-
gation of individual genes/transcripts and providing a means 
of selecting candidate genes and transcripts for experimental 
validation and future research. The lists of genes and tran-
scripts with significant changes in DE/DAS/DTU can be 
downloaded and exported out of 3D RNA-seq for gene ontol-
ogy (GO) enrichment analysis using appropriate web data-
bases or GO analysis programs. The significantly enriched 
annotation results can be re-imported into the 3D RNA-seq 
App to generate GO annotation plots (Supplementary Figure 
S6 and see Fig. 4C,D). To generate publication-quality figures, 
users can set widths, heights, resolution and colours for his-
tograms, plots, heat-maps etc. to be saved. The analysis 
reports contain full details of the custom-configured para-
meters, methods and results tables and figures from the entire 
3D analysis. The analysis report is a detailed document that 
guarantees the reproducibility of the analysis and results.
3D RNA-seq adopts the best practice and integrates the 
state-of-art methods for DE and DAS analysis
3D RNA-seq adopts best practice and integrates state-of-art 
methods for RNA-seq data pre-processing: 1) Tximport to con-
vert TPM values to read counts while taking transcript length 
and sequencing depth into account [26]; 2) mean-variance trend 
plots to filter low expressed genes/transcripts to improve fit to 
statistical models and remove discrepancies due to read count 
distribution assumptions [7]; 3) PCA plots to visualize sample 
variances and identify technical effects; 4) RUVSeq to estimate 
batch effects [15]; 5) a number of read count normalization 
methods to correct the variances and reduce the false positives 
for highly abundant transcript outliers [29].
Limma voom [7] was chosen as the engine for the DE analysis 
(DE, DAS and DTU) for five reasons. Firstly, from different 
studies, Limma is consistently one of the best performing meth-
ods for RNA-seq differential expression analysis and has a good 
control of FDR [10,40,41]. Secondly, it allows both the DE and 
DAS analysis within the same framework. More importantly, the 
DE analysis and DAS analysis differentiates genes that are 
affected by transcriptional regulation (e.g. by transcriptional 
factors) and alternative splicing regulation (e.g. by splicing fac-
tors) as shown in Fig. 3–7. Thirdly, Limma employs a linear 
model that runs very quickly and compared with methods 
requiring bootstrapping data, such as Sleuth [10], the running 
time and memory required is significantly reduced. Fourthly, 
Limma has good compatibility with other bioinformatics 
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R packages for a range of other functions, such as estimation of 
batch effects and normalization of sequencing biases. In addition 
to batch effects that occur systematically for all the samples in 
a certain biological replicate, RNA-seq data may have variations 
in sample quality due to, for example, degradation or contam-
ination of specific samples. These problematic samples are often 
shown as outliers in the PCA plot. The Limma- 
voomWithQualityWeights function has been incorporated in 
the 3D RNA-seq App to balance the outliners [7,42]. Lastly, 
but most importantly, Limma allows flexible experimental 
designs, where any pairs or groups of samples can be compared 
in contrast to most of the current DE tools which offer limited 
choices for comparisons.
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